MURFU — Conduit Pharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00- $989.08m
- $989.55m
Annual balance sheet for Conduit Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | |
|---|---|---|
| Period Length: | — | — |
| Source: | 10-K | 10-K |
| Standards: | USG | USG |
| Status: | Final | Final |
| Cash | ||
| Cash and Short Term Investments | 0.049 | 0.346 |
| Prepaid Expenses | ||
| Total Current Assets | 0.104 | 0.647 |
| Other Long Term Assets | ||
| Total Assets | 0.213 | 138 |
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Total Other Current Liabilities | ||
| Total Current Liabilities | 0.193 | 0.418 |
| Total Long Term Debt | ||
| Total Debt | ||
| Total Other Liabilities | ||
| Total Liabilities | 0.193 | 5.05 |
| Non Redeemable Preferred Stock | ||
| Common Stock | ||
| Additional Paid In Capital | ||
| Retained Earnings (Accumulated Deficit) | ||
| Total Equity | 0.021 | 132 |
| Total Liabilities & Shareholders' Equity | 0.213 | 138 |
| Total Common Shares Outstanding |